The efficacy of two formulations of botulinum toxin type A for masseter reduction: a split-face comparison study
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2016.1263382
Abstract: Abstract Background: Botulinum toxin type A (BTA) is now extensively used to address cosmetic concerns. OnabotulinumtoxinA (ONA, Botox; Allergan Inc., Irvine, CA) received FDA approval for upper face rejuvenation, including glabella frown lines and crow’s-feet… read more here.
Keywords: ona nbt; efficacy; face; masseter ... See more keywords